Rising accident and emergency attendance rates are driven by patients’ long term health conditions, and are not related to lack of GP provision, according to a study by Queen Mary University of London of more than 800,000 patients in east London.
Theatre project boosts peer support for young people with asthma
11 September 2017
An innovative theatre project and a game app have been presented by Queen Mary University of London (QMUL) researchers at the British Science Festival as new ways to help teenagers with asthma.
The rapper Professor Green is helping to raise funds for trauma research at Queen Mary University of London (QMUL) in a major appeal led by Barts Charity.
Pregnant women who have a healthy diet and regular moderate exercise are less likely to have a caesarean section, gain excessive weight, or develop diabetes in pregnancy, according to a study led by Queen Mary University of London (QMUL) using data from over 12,000 women.
High maternal sugar intake during pregnancy may increase the risk of allergy and allergic asthma in the offspring, according to an early study led by Queen Mary University of London (QMUL) involving almost 9,000 mother-child pairs
The Blizard Institute’s science education centre, Centre of the Cell, reached a milestone of 150,000 participants in June 2017.
The Blizard institute is very pleased to be able to celebrate the inaugural lecture of Professor Nick Croft which took place on Wednesday 28 June and addressed ‘Children, Digestive Diseases and the Grand National’.
Congratulations to Professor Parveen Kumar who was named in the Queen's annual Birthday Honours' list; been conferred the prestigious Dames Commander of the Order of the British Empire (DBE) for services to medicine and medical education.
Congratulations to Professor Denise Sheer who will be collaborating in a ground-breaking £5 million investment for research into Paediatric Low Grade Brain Tumours
The Blizard institute is very pleased to be able to celebrate the inaugural lecture of Professor Tom Vulliamy which took place on Friday the 15 June 2017. The lecture was title ‘Searching for genes – a long unwinding road’.
Through a Freedom of Information request to the European Medicines Agency, researchers from Queen Mary University of London (QMUL) have gained access to data from drug trials, revealing new information about a key drug for multiple sclerosis (MS).
Queen Mary University of London (QMUL) will establish a new Centre for Preventive Neurology, thanks to £1.5m of funding from Barts Charity.
The research, published in BMJ Open, analysed posts written by teenagers and their parents from Asthma UK’s online forum between 2006 and 2016. It found that the social stigma of asthma can play a role in teenagers choosing not to use their inhalers.
Queen Mary University of London (QMUL) has received £2m from Barts Charity to launch the Barts Research Centre for Women's Health, with the aim of tackling problems that affect mothers and their unborn and newborn children
Some common assumptions about the nature of multiple sclerosis (MS) are being challenged in two new studies led by Queen Mary University of London (QMUL) that analyse the brains and spinal cords of patients.
Queen Mary University of London (QMUL) will establish a new Centre for Preventive Neurology, thanks to £1.5m of funding from Barts Charity.
Study makes Anti-ageing breakthrough
6 April 2017
The Health Foundation, an independent charity, has today announced funding in the region of £40 million over a period of 10 years for the University of Cambridge to establish and run a new improvement research institute, the first of its kind in Europe.
A new tool developed by researchers from Queen Mary University of London (QMUL) could save mothers’ and babies’ lives by predicting whether women with early onset pre-eclampsia are safe to prolong their pregnancy.
Londoners were warned of 'very high' pollution levels earlier this year AFP/Getty Images
QMUL professor selected as NIHR senior investigator
30 March 2017
Congratulations to Professor Sandra Eldridge from the Centre for Primary Care and Public Health, who has been selected as a National Institute for Health Research (NIHR) senior investigator. Sandra’s success in this highly competitive process means that she will become a member of the NIHR College of around 200 senior investigators, charged with helping to shape and influence the future direction of health research and its benefits to the nation.
The snake skin woman: Extraordinary people
29 March 2017
Congratulations to Dr Rosalind Hannen and Professor Kenny Linton who have been successful in securing an award from MedCity’s new ‘Collaborate to Innovate’ scheme. The £2m ‘Collaborate to Innovate programme, led by King’s College London and part-funded by ERDF and HEFCE, is connecting 16 life sciences SMEs with leading academics to address a specific challenge related to their product or service.
New protein discovered in ageing and cancer
9 March 2017
A protein has been found to have a previously unknown role in the ageing of cells, according to an early study by Queen Mary University of London (QMUL). The researchers hope that the findings could one day lead to new treatments for ageing and early cancer.
Blizard students publish in Journal of Physiology
24 February 2017
(pictured first author, Meneka Kanagaratnam)
Blizard Club - Paper of the Year 2016
23 February 2017
More than 280 doctors, nurses and other health professionals have signed a letter to Theresa May calling for national action to dramatically cut the number of diesel cars, vans, taxis and light trucks to protect a generation of young children.
Queen Mary University of London (QMUL) and NHS Blood & Transplant have been awarded £2.4m from the National Institute for Health Research and Barts Charity to carry out a large multi-centre clinical trial to evaluate a new treatment in major traumatic haemorrhage
Engagement and Enterprise Awards 2017
8 February 2017
David Kelsell, winner of the CHANEL-CERIES Research Award 2016
30 January 2017
Congratulations to Prof David Kelsell, winner of the CHANEL-CERIES Research Award 2016 for his work on skin molecular mechanisms and to the Kelsell Research Group for their recent publication in Nature Communications.
QMUL and BH announce major new initiative in the Life Sciences
25 January 2017
Queen Mary University of London (QMUL) and Barts Health NHS Trust (BH) announce plans for a major new centre for Life Sciences in Whitechapel, home to the Royal London Hospital and a campus of QMUL’s Barts and The London School of Medicine and Dentistry.
Scar Academy 2016
19 January 2017
Queen Mary University of London in collaboration with Oscare, Belgium organised a two day multidisciplinary conference called: ‘Scar Academy 2016’ last month in London
£1m awarded for global health research
19 January 2017
Researchers from Queen Mary University of London (QMUL) have been awarded grants totalling £1m for medical research projects in low and middle income countries (LMICs)
Barts Innovations in Healthcare Awards - Winners
19 January 2017
Congratulations to the winners of the Barts Innovations in Healthcare Awards November 2016!
Dr Neil McCarthy, pictured above (right) with supervisor Dr Andy Stagg, from the Centre for Immunobiology, was awarded the prize for best oral presentation in the ECR session at the UCL Infection, Immunology and Inflammation Symposium.
Giant ‘nerve cell’ to be built in London’s East End
25 November 2016
Planning permission has been granted for the construction of a new science education space in Whitechapel, East London at Centre of the Cell, Queen Mary University of London (QMUL).
Prof Karim Brohi wins Lifetime Achievement Award for Trauma Research
25 November 2016
Karim Brohi, Professor of Trauma Sciences in the Centre for Neuroscience and Trauma, has received a Lifetime Achievement Award in Resuscitation Science from the American Heart Association.
MS drug may reverse some physical disability
13 October 2016
Alemtuzumab is used in relapsing-remitting MS, the most common form of the disease, in which symptoms alternate between sudden worsening and remission. Because it can cause serious side effects, the drug is generally used in people who have not responded well to other drugs. In this study, however, it was used relatively early in the course of MS.
Collecting injury data could reduce emergency attendances
13 October 2016
Multi-drug-resistant TB cure rates higher than expected
15 September 2016
Cure rates for multi-drug-resistant tuberculosis (MDR-TB) in Europe have been estimated to be twice as high as previously thought, according to a research team in the Centre for Immunobiology here at the Blizard Institute, Queen Mary University of London (QMUL).
Most twins should be delivered at 37 weeks to minimise deaths
7 September 2016
Scientists from the Centre for Primary Care and Public Health have analysed the twin pregnancies of more than 30,000 women to identify the ideal delivery period in an attempt to reduce rates of stillbirth.
Vitamin D protects against severe asthma attacks
6 September 2016
Taking oral vitamin D supplements in addition to standard asthma medication could halve the risk of asthma attacks requiring hospital attendance, according to research led by Queen Mary University of London (QMUL).
Blizard AfterTrauma Nominated for Times Higher Education Award 2016
2 September 2016
AfterTrauma – Nominated for Outstanding Contribution to Innovation and Technology in Times Higher Education Awards 2016
The process by which a mother’s diet during pregnancy can permanently affect her offspring’s attributes, such as weight, could be strongly influenced by genetic variation in an unexpected part of the genome, according to research led by Prof Vardhman Rakyan from the Centre for Genomics and Child Health.
Community-based programme improves depression in chronic pain patients
Queen Mary University of London has been ranked the 34th best university in the UK by The Guardian University Guide 2017.
Blizard Institute Announces its first Paper of the Year Winners
26 February 2016
In February 2015 an initiative was started in the Blizard Institute to recognise outstanding publications by our researchers. Each month, a shortlist is prepared by Prof David Kelsell, Deputy Director for Research, and Prof Graham Hitman, Institute Director, and sent out for all Blizard Institute staff and students to vote on. The winning publication becomes the Blizard Paper of the Month and at the end of the calendar year these are in turn entered into an open vote for Blizard Paper of the Year.
Congratulations are due to Professor Graham Foster and his team in the Centre for Immunobiology for the below publication. Hepatitis C is a global problem and this treatment will go a long way to reducing the global burden of this disease. The impact of this work cannot be underestimated.
Blizard Building Marks 10 Year Anniversary
9 December 2015
The iconic RIBA award winning building was opened by Princess Anne in October 2005, and over the past ten years has seen major advances in the research areas of cell biology, genomics, immunology, neuroscience, trauma, primary care and public health.
Students triumph at Biotechnology Entrepreneurs Scheme
29 October 2015
A team of Queen Mary postgraduate students are through to the final of the annual Biotechnology YES (Young Entrepreneur Scheme) competition.
The Medical Research Council (MRC) has awarded a grant of £3.5m to researchers from the Blizard Institute, Queen Mary University of London (QMUL), and University of Cape Town (UCT) to carry out a trial to determine whether a weekly vitamin D supplement can prevent tuberculosis (TB) in South African primary school children.
New study removes cancer doubt for Multiple sclerosis drug
12 October 2015
Researchers from the Blizard Institute at Queen Mary University of London (QMUL) are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis (MS) after new evidence shows it does not increase the risk of cancer as previously thought.
QMUL ranked in top 100 universities in the world
1 October 2015
Queen Mary University of London has been ranked in the top 100 universities in the world in the 2015/16 Times Higher Education World University Rankings:
Two Blizard Institute Researchers Awarded Young Investigator Awards by the International Society for Chemotherapy and Cancer
Andy Prendergast from the Centre for Genomics and Child Health has been awarded a five-year Wellcome Trust Senior Clinical Fellowship to continue work he is undertaking in Zimbabwe on malnutrition. His group is exploring interventions to prevent stunting in childhood - an often overlooked form of chronic malnutrition which increases mortality from infections and impairs long-term child development. His current work on the SHINE trial is evalauting the independent and combined effects of improving water/hygiene/sanitation or infant feeding on stunting. In his Senior Fellowship, Andy has been awarded £2M from the Wellcome Trust to undertake a trial to evaluate the impact of the antibiotic cotrimoxazole on birth outcomes and growth in rural Zimbabwe. Antenatal women will be randomized to cotrimoxazole or placebo to see whether antibiotics reduces prematurity and increase birth weight, then infants will be randomized to cotrimoxazole or placebo to evaluate the impact of antibiotics on linear growth by 6 months. Specimens will be collected from mothers and infants to explore the impact of antibiotics on inflammation, immune function, intestinal inflammation and the microbiota, in laboratory work to be undertaken in Zimbabwe and at the Blizard Institute.
Blizard Researcher wins Best Offered Paper Prize
30 June 2015
Professor Sandra Eldridge from the Centre for Primary Care and Public Health has been awarded an Honorary Fellowship of the Royal College of General Practitioners.
Dr Protima Amon, Clinical Research Fellow in Paediatric Gastroenterology, won 1st prize in the QMUL Three Minute Thesis (3MT™) competition on Thursday 11th June for her talk entitled: “It’s a bug’s life”. Her PhD work examines the bacteria in children who have inflammation in the intestine.
A simple blood test can predict with 90 to 100 per cent accuracy whether a patient is likely to suffer life-threatening complications after major surgery, according to new research from Blizard Institute, Queen Mary University of London, and published in the journal Annals of Surgery.
The governing body of the British Neuro-Oncology Society has unanimously supported the nomination of Professor Silvia Marino, based within the Centre for Genomics and Child Health here at the Blizard Institute, as the new Vice President of the society. Professor Marino will serve for two years as Vice President from July 2015 before succeeding the incoming President, Mr David Jellinek, in July 2017. The Society’s mission is to promote research and education in Neuro-Oncology and to improve treatment of patients with tumours of the central nervous system.
Blizard Institute's Professor David Kelsell and colleagues including Professor Andy Silver have been awarded a £1.1million Cancer Research UK (CRUK) programme grant to work on squamous oesophageal cancer.
Norman Williams, Professor of Surgery in the Blizard Institute, has been awarded a knighthood in the 2015 New Year’s Honours for services to surgery.
The results of the Research Excellence Framework (REF), published 18th December 2014, confirm Queen Mary University of London (QMUL)’s place in the very top group of research-led universities.
Dr Neha Pathak, an Academic Clinical Fellow from Queen Mary University of London, was last night awarded the ‘Ultimate Game Changer’ prize at the Cosmopolitan Ultimate Women Awards.
The 4th Annual Society of British Neurological Surgeons (SBNS) and Neurology & NeuroSurgery Interest Group (NANSIG) conference took place (22/11/14) at the Royal College of Surgeons (RCS), London. The SBNS comprises some of the most highly respected neurosurgeons and researchers in neuroscience across the UK. In partnership with NANSIG, it hosts the annual B.Braun Undergraduate Research prize, an annual prize for the most outstanding undergraduate research in neuroscience in the U.K. This year the prestigious prize was won by Amy Bowes, a final year medical student at the School of Medicine and Dentistry and research assistant for the Centre for Trauma Science’s (C4TS) Neurotrauma and Neurodegeneration Group.
Professor Allyson Pollock replies to questions on the ebola crisis – originally asked prior to the BBC Politics show on 19 October
William Harvey Day – Tuesday 21st October 2014
A ground-breaking new research partnership with UCL Institute of Neurology (under UCLPartners) and the charity Brain Tumour Research begins today, as the Brain Tumour Research Centre of Excellence launches. The partnership starts a new chapter in long-term, sustainable and continuous research into brain tumours, the biggest cancer killer of children and adults under 40.
New Students! Click here for Induction and Enrolment Details
17 September 2014
QMUL Induction for International Students:
A campaign to put patient care at the centre of evidence-based medicine (EBM) is launched by Professor Trish Greenhalgh, Public Health expert at Centre for Primary Care and Public Health, Blizard Institute, Queen Mary University of London, at the BioMed Central’s Health Services Research conference at Kings’ College London.
Asthma affects one in 11 children and young people in the UK. On average, this is two children in every classroom. Scientists from the Blizard Institute are launching a new study to measure the impact asthma has on school children, with the aim of improving school life for those with asthma.
Queen Mary University of London is delighted to announce a ground-breaking new research partnership with UCL Institute of Neurology (under UCLPartners) and the charity Brain Tumour Research. The partnership begins a new chapter in long-term, sustainable and continuous research into brain tumours, the biggest cancer killer of children and adults under 40. Formally presented to MPs at a reception in Speaker’s House today, the research is led by Professor Silvia Marino, a leading brain tumour scientist and neuropathologist based within Queen Mary’s Blizard Institute. Professor Sheer, also from Queen Mary, and Professor Brandner and Dr Rees at UCL Institute of Neurology will be the other key partners in this initiative. The research will focus on glioblastoma multiforme (GBM), the most common and most aggressive type of malignant brain tumour found in humans. The aim of the research is to increase our understanding of the cells within the brain from which GBM originates. The team will look at how this particular type of brain tumour develops from normal cells, and determine which genes and biological functions control its behaviour. By uncovering this essential knowledge, the clinical evaluation of each individual patient can be improved and better and more specific drugs which target the tumour cells can be identified. Silvia Marino, Professor of Neuropathology at Queen Mary University of London, comments: “We know a cure for glioblastoma can and will be found – and this funding boost will hopefully enable significant steps towards a breakthrough. The plan for our centre of excellence is to specialise in adult glioblastoma as we have a wealth of experience in the field, ranging from preclinical experimental models to advanced genomics for direct patient benefit. We also look forward to strengthening collaborative links between us and the UCL Institute of Neurology.” The partnership is part of the charity’s aim for a £20 million investment in brain tumour research over the next five years. Brain Tumour Research aims to establish seven Research Centres of Excellence across the UK, building a ‘critical mass’ of research teams and aiming to bring the UK to the forefront of brain tumour research. With secure long-term funding, researchers will be able to pursue the sustainable and continuous research so desperately needed by the scientists and clinicians working in the heavily underfunded field of brain tumour research. Promising scientists will be trained up through the ranks and as specialist brain tumour expertise and knowledge builds, experienced researchers can then move between Centres to encourage cross-pollination of the very best thinking at the cutting-edge of brain tumour research. Sue Farrington Smith, Chief Executive of Brain Tumour Research, comments: “Today we will be forming a powerful new network of researchers in order to accelerate progress in brain tumour research and make a clinical difference. All partners involved share a vision of a sustainable and secure environment for research into brain tumours in the UK, ultimately creating better futures for all those diagnosed and living with a brain tumour. We are determined to do all we can to change this, and to one day find a cure for this devastating disease.” Queen Mary would also like to thank Barts Charity, for their supporting role in this partnership.